Which U.S. Biopharma Clusters Will Lead in 2025?

U.S. biopharma clusters are responding to high interest rates, NIH restructuring, and FDA changes while maintaining investment in research and development. Boston/Cambridge, San Francisco Bay Area, BioHealth Capital Region, New York/New Jersey, San Diego, Los Angeles/Orange County, Greater Philadelphia, North Carolina, Seattle, and Chicagoland rank as the top ten regions based on patents, NIH funding, venture capital, laboratory space, and jobs. Major projects, mergers, and facility expansions are underway in these regions, with efforts focused on addressing unmet medical needs, supporting domestic drug manufacturing, and advancing biotechnology for national security and economic growth.Learn more on this news by visiting us at: https://greyjournal.net/news/ Hosted on Acast. See acast.com/privacy for more information.